Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 114 participants.
Also called NCT01972724
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 114 participants
- Sponsor
- Registry
-
NCT01972724
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01972724. Randomized; no masking; primary purpose treatment. Start 2013-12-16 (actual); primary completion 2016-10-17 (actual). Results posted on 2018-07-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral Therapy
- Acronym
- ADD
- Condition
- Type II Diabetes Mellitus
- Intervention (Drug)
- Pioglitazone
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Sulfonylurea
- Lead sponsor
- Takeda
Record details
- Record id
cardio:ct-nct01972724- Content hash
7a04493337f34f4590f351b3f1e995c425282726d4226479113e9c7d2d3bb332